Deutsch
English
Español
Français
Nederlands
Português
What Happened to Crown Princess Mette-Marit?
Norway's Crown Princess Mette-Marit, 52, has been placed on the national lung transplant waiting list after her chronic lung disease reached a life-threatening stage. The announcement came from the Norwegian Royal Palace on June 5, 2026, following extensive medical examinations at Oslo University Hospital. The crown princess, diagnosed with pulmonary fibrosis in 2018, now requires a lung transplant as soon as a suitable donor becomes available.
Understanding Pulmonary Fibrosis: The Disease Behind the Crisis
Pulmonary fibrosis is a progressive lung disease characterized by scarring (fibrosis) of lung tissue, which makes it increasingly difficult for the lungs to absorb oxygen. In Mette-Marit's case, the condition has worsened significantly over the past year, requiring her to use supplemental oxygen in public. The disease has no known cure, and lung transplantation is often the only life-saving treatment option in advanced stages.
According to the Norwegian Royal Court, the crown princess's condition is now considered life-threatening. Professor Are Holm of Oslo University Hospital confirmed that she was placed on the transplant list following comprehensive evaluations. The Scandiatransplant organ sharing network covers approximately 29.8 million people across Nordic countries. Around 30 lung transplants are performed annually in Norway, with average waiting times of about six months, though allocation depends on medical urgency and donor compatibility rather than chronological order.
Impact on Royal Duties and Family Life
While awaiting the operation, Mette-Marit cannot perform her official royal duties. This has triggered a cascade of schedule changes within the Norwegian royal family. Crown Prince Haakon has cut short an official visit to Japan to be by his wife's side and will significantly limit travel—both domestically and abroad—before and after the surgery. He will also miss the 50th wedding anniversary celebrations of Sweden's King Carl Gustaf and Queen Silvia in Stockholm.
The couple has postponed their silver wedding anniversary celebration, originally planned for August 2026. The crown princess will also skip a planned official visit to a Norwegian county in September. Their daughter, Princess Ingrid Alexandra, 22, has returned from her studies at the University of Sydney in Australia to spend the autumn semester at the University of Oslo, staying closer to her mother. Their son, Prince Sverre Magnus, 20, plans to begin studies in Europe but will return to Norway whenever needed.
Similar to the 2025 Norwegian royal family health updates, this situation has drawn widespread public sympathy and attention to chronic lung disease awareness.
A Challenging Year for the Norwegian Royal Family
The health crisis comes amid other significant challenges for the royal household. Mette-Marit's eldest son, Marius Borg Høiby (from a previous relationship), is currently standing trial for 38 criminal charges, including the rape of four women. Prosecutors have sought a prison sentence of more than 7.5 years. The case has been described as a major strain on the monarchy.
Additionally, the crown princess faced public scrutiny earlier this year when email exchanges between her and convicted sex offender Jeffrey Epstein were released by U.S. authorities. The correspondence revealed regular contact even after Epstein's 2008 conviction for sex trafficking. In a televised interview, Mette-Marit expressed regret, stating: 'I should have warned people about Epstein.' She later issued a formal apology through the palace.
Despite these pressures, Norwegian Prime Minister Jonas Gahr Støre praised the crown princess for her openness about her health struggles, noting that her transparency could help others facing similar diagnoses. Experts in European royal health transparency have pointed to her case as a model for public communication.
What Is the Prognosis for a Lung Transplant?
Lung transplantation carries significant risks, including organ rejection, infection, and long-term immunosuppression. However, for patients with end-stage pulmonary fibrosis, it offers the best chance for extended survival and improved quality of life. The average survival rate after lung transplant is approximately 5-6 years, though many patients live much longer with proper medical care.
The Norwegian Royal Court has stated that the crown princess will undergo the operation at Oslo University Hospital as soon as a suitable donor is found. The family has requested privacy during this difficult period but has committed to providing updates when appropriate.
Frequently Asked Questions
What is pulmonary fibrosis?
Pulmonary fibrosis is a chronic lung disease where lung tissue becomes scarred and thickened, making it progressively harder to breathe. It is incurable and can be life-threatening in advanced stages.
How long is the waiting list for a lung transplant in Norway?
The average waiting time is about six months, but it varies based on medical urgency, blood type, donor organ availability, and compatibility. Norway participates in the Scandiatransplant network, which covers Nordic countries.
Can Mette-Marit continue her royal duties while waiting?
No. The palace announced she is unable to work or carry out official engagements while awaiting the transplant. Her public schedule has been suspended indefinitely.
What happens if no donor is found in time?
Without a transplant, the prognosis for end-stage pulmonary fibrosis is poor. However, the palace and medical team remain hopeful that a suitable donor will be identified through the Nordic organ-sharing system.
How has the Norwegian public reacted?
The public response has been overwhelmingly sympathetic. Many Norwegians have expressed support for the crown princess, and the prime minister praised her openness about her condition, saying it could help destigmatize chronic illness.
Follow Discussion